Unicycive Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
Mountain View, California – Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq:UNCY), a biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer, will present at the Guggenheim 3rd Annual Healthcare Innovation Conference on Tuesday, November 10, 2026, at 2:30 p.m. ET. Unicycive Therapeutics, Inc. is a B2i […]
Source: investorshub.advfn.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.
